CMC Strategy Forum China

The CMC Strategy Forum Japan is a leading scientific meeting that convenes regulatory, industry, and academic experts to address emerging CMC issues in biotechnology through open, transparent workshops. The Forum explores critical topics that define the biotech industry’s challenges, emphasizing CMC issues across a product's lifecycle. The CMC Strategy Forum works with industry and regulatory agencies to harmonize scientific and regulatory practices. Adhering to the established CMC Forum series model, the Forum highlights topics and regulatory updates pertinent to China. With strong collaboration, partnership, and leadership of the China Center for Food and Drug International Exchange (CCFDIE), we launched a joint CCFDIE/CASSS CMC Strategy Forum China Livestream 2021 Pilot Program. This project was in the making for a few years and reflects the growing importance, innovation, and leadership that the Chinese Health Authority (NMPA-National Medical Products Administration), as well as the China biotech industry, play on a global basis. 

For more information, contact Dave Bergeson.


Click on the tab below to view Speaker Presentations from the most recent meeting, as well as all Summary Papers. 

CASSS On Demand

Access approved content from past meetings in the NEW CASSS On Demand platform. CASSS members have access to all available presentation recordings. Visit, login to your account, and select from the list of meetings to begin.

Explore CASSS
On Demand

Review Resources

Want to revisit a keynote presentation? Missed important details that may impact your work?

Visit Papers and Presentations to access relevant presentations, summary papers, and roundtable notes.

Thank You for Joining Us

We appreciate your participation in CMC Strategy Forum China 2022.

Image with text 'CMC Strategy Forum Advancing Biopharmaceutical Development China 2022 Virtual Forum 2-3 November'